Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Incyte announced results from a Phase 3 trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea.
Ferumoxytol and iron sucrose have comparable safety in the treatment of anemia in patients with CKD.
For patients with established cardiovascular disease and atrial fibrillation, warfarin treatment correlates with a lower risk of a composite of death, myocardial infarction (MI), and ischemic stroke, with no increased risk of bleeding.
Nurse awareness of this treatment option and the patient selection criteria may be a significant ...
This module reviews all topics on the NCCPA examination blueprint relating to the Infectious Disease, ...